Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient

被引：0

作者：

Boucher, M. ^{[1
]}

Mezquita, L. ^{[2
]}

Auclin, E. ^{[3
]}

Mons, M. ^{[4
]}

Marghadi, J. ^{[4
]}

Charrier, M. ^{[4
]}

Ferrara, R. ^{[2
]}

Planchard, D. ^{[5
]}

Anas, G. ^{[1
]}

Le Pechoux, C. ^{[6
]}

Botticella, A. ^{[7
]}

Caramella, C. ^{[4
]}

Adam, J. ^{[8
]}

Soria, J. ^{[9
]}

Besse, B. ^{[1
]}

机构：

[1] Inst Gustave Roussy, Med Oncol, Villejuif, France

[2] Gustave Roussy, Med Oncol Dept, Villejuif, France

[3] Hop Georges Pompidou, Paris, France

[4] Gustave Roussy, Villejuif, France

[5] Gustave Roussy, Med Oncol, Villejuif, France

[6] Gustave Roussy, Radiat Oncol, Villejuif, France

[7] Gustave Roussy, Radiotherapy, Villejuif, France

[8] Gustave Roussy Canc Campus, Dept Med Biol & Pathol, Villejuif, France

[9] Gustave Roussy Canc Campus, Drug Dev Dept, Paris, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

frailty; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.01-038

引用

页码：S2082 / S2083

页数：2

共 50 条

[31] Vinorelbine in the treatment of non-small cell lung cancer
Gridelli, C
De Vivo, R
[J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (08) : 879 - 891
[32] Atezolizumab for the treatment of non-small cell lung cancer
Santini, Fernando C.
Rudin, Charles M.
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (09) : 935 - 945
[33] Advances in treatment for non-small cell lung cancer
Price, Katharine A.
Jett, James R.
[J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (07) : 792 - 794
[34] Targeted Treatment for the Non-Small Cell Lung Cancer
Komaki, R.
[J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S59 - S60
[35] Trastuzumab in the treatment of non-small cell lung cancer
Azzoli, CG
Krug, LM
Miller, VA
Kris, MG
Mass, R
[J]. SEMINARS IN ONCOLOGY, 2002, 29 (01) : 59 - 65
[36] Vinflunine for the treatment of non-small cell lung cancer
Genova, C.
Alama, A.
Coco, S.
Rijavec, E.
Dal Bello, M. G.
Vanni, I.
Biello, F.
Barletta, G.
Rossi, G.
Grossi, F.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (12) : 1447 - 1455
[37] Topotecan in the treatment of non-small cell lung cancer
Perez-Soler, R
[J]. SEMINARS IN ONCOLOGY, 1997, 24 (06) : S34 - S41
[38] Chemotherapy in the treatment of non-small cell lung cancer
Hainsworth, JD
[J]. AMERICAN FAMILY PHYSICIAN, 1997, 55 (06) : 2265 - +
[39] Pemetrexed for the treatment of non-small cell lung cancer
Genova, Carlo
Rijavec, Erika
Truini, Anna
Coco, Simona
Sini, Claudio
Barletta, Giulia
Dal Bello, Maria Giovanna
Alama, Angela
Savarino, Grazia
Pronzato, Paolo
Boccardo, Francesco
Grossi, Francesco
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (11) : 1545 - 1558
[40] Surgical treatment of non-small cell lung cancer
De Leyn, P
Decker, G
[J]. REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (05) : 971 - 982

← 1 2 3 4 5 →